𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas

✍ Scribed by Yan Zhang; Yoshiko Hiraishi; Hua Wang; Ken-saku Sumi; Yasutaka Hayashido; Shigeaki Toratani; Mikio Kan; J. Denry Sato; Tetsuji Okamoto

Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
200 KB
Volume
117
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

A G to T mutation at nucleotide position 2128 in the human FGFR3b coding region resulting in a Cys for Gly substitution (G697C) in the tyrosine kinase domain was observed in 62% (44/71) of oral squamous cell carcinomas (OSCC) examined. Immunostained FGFR3b was found in the cytoplasm of prickle cells in normal epithelia, and FGFR3b was localized in the cytoplasm and nucleus in non-FGFR3b mutant OSCC. Overexpressed FGFR3b protein on plasma membranes was noted in OSCC bearing the FGFR3b mutation. Enhanced tyrosine kinase activity of G697CFGFR3b was confirmed. Our results indicate that G697C is an activating mutation causing constitutive ligand-independent FGFR3b signaling. This mutation may be involved in the progression of OSCC and thus the FGFR3b coding sequence may have diagnostic or prognostic value for OSCC.

πŸ“œ SIMILAR VOLUMES

Analysis of fibroblast growth factor rec
Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas
✍ Johannes Aubertin; Sophie Tourpin; FranΓ§ois Janot; Jean-Charles Ahomadegbe; Fran πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 154 KB

Zhang et al. recently reported an activating mutation of the receptor tyrosine kinase fibroblast growth factor receptor 3 in 62% of 71 oral squamous cell carcinomas (OSCC). 1 More than 300,000 new cases of OSCC are diagnosed annually, worldwide. This aggressive epithelial cancer is associated with s

No mutations of FGFR3 in normal urotheli
No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer
✍ Wolfgang Otto; Stefan Denzinger; Simone Bertz; Andreas Gaumann; Peter J. Wild; A πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 94 KB

## Abstract Mutations in the fibroblast growth factor receptor 3 (__FGFR3__) gene causing constitutive oncogenic protein activation have been shown to be frequent in papillary noninvasive bladder tumours and are associated with a low risk of progression and a favourable outcome. __FGFR3__ alteratio

Tumor-specific mutation and downregulati
Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma
✍ Beyhan Cengiz; Esra Gunduz; Mehmet Gunduz; Levent Bekir Beder; Ryo Tamamura; Cah πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 346 KB

## Abstract Our previous study showed high frequency of allelic loss at chromosome 2q37 region in oral cancer. This location contains several candidate tumor suppressor genes such as __PPP1R7, ILKAP__, __DTYMK__ and __ING5__. We previously showed 3 members of inhibitor of growth (__ING__) family, _